Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ 4EBP1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA582838
Description
Immunogen sequence: PGGTRIIYDR KFLMECRNSP VTKTPPRDLP TIPGVTSPSS DEPPMEASQS HLRNSPEDKR AGGEESQFEM DI.
This gene encodes one member of a family of translation repressor proteins. The protein directly interacts with eukaryotic translation initiation factor 4E, which is a limiting component of the multisubunit complex that recruits 40S ribosomal subunits to the 5' end of mRNAs. Interaction of this protein with eIF4E inhibits complex assembly and represses translation. This protein is phosphorylated in response to various signals including UV irradiation and insulin signaling, resulting in its dissociation from eIF4E and activation of mRNA translation.
Specifications
4EBP1 | |
Polyclonal | |
Unconjugated | |
EIF4EBP1 | |
4EBP1; 4E-BP1; AA959816; BP-1; eIF4E-binding protein 1; EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1; eukaryotic translation initiation factor 4E-binding protein 1; MGC431; MGC4316; P/OKCL.6; PHAS-1; PHAS-I; Phosphorylated heat- and acid-stable protein regulated by insulin 1 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
116636, 13685, 1978 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
0.05 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q13541, Q60876, Q62622 | |
EIF4EBP1 | |
Recombinant protein corresponding to Human EIF4EBP1. Recombinant protein control fragment (Product #RP-93944). | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction